Advent International to invest Rs. 16,650 crs in Telangana’s life sciences sector

Advent International, one of the world’s largest and most experienced private equity investors, is significantly amplifying its presence within Hyderabad’s flourishing life sciences landscape with a substantial Rs. 9,589 crore investment to acquire a controlling stake in Suven Pharmaceuticals and to also establish a 50,000 sft R&D lab in Genome Valley. 

Advent’s investment and ambitious growth plans were discussed today at a meeting between Mr. Pankaj Patwari, Managing Director, Advent International and Mr. Vaidheesh Annaswamy, Operating Partner, Advent International, and the Hon’ble Minister Shri. KT Rama Rao, Mr. Jayesh Ranjan IAS, Principal Secretary of the Industries and Commerce Department, and Mr. Shakthi M Nagappan, Chief Executive Officer of Telangana Life Sciences. 

Earlier, Advent’s Managing Partner, Mr John Maldonado had engaged in a productive meeting with the Hon’ble Minister, Mt KT Rama Rao, during his visit to the United States in 2022. Advent’s commitment to the Hyderabad pharmaceutical sector was further solidified by the creation of the “Cohance platform”, encompassing its API and contract development and manufacturing businesses — RA Chem Pharma, ZCL Chemicals, and Avra Laboratories with Hyderabad as its headquarters. These pivotal investments mark a significant advancement in the city’s trajectory as an emerging hub for pioneering life sciences innovation and exponential growth. 

The current investments underscore Advent’s dedication to bolstering its Cohance platform, with a combined investment of about USD 2 bn (approx Rs.16,650 Crores) , which is the largest investment of its kind in Asia, aspiring to be among the top three API and Contract Development and Manufacturing (CDMO) companies / platforms. 

Commenting on the strategic partnership, Minister KT Rama Rao said, “I’m delighted to witness the remarkable growth of Advent International’s portfolio in Hyderabad’s life sciences sector. Their journey of multiple investments and remarkable expansion in Telangana exemplifies the vibrant ecosystem that the government and industry partners have collaboratively nurtured. I am confident that Advent will continue to thrive in Telangana, and we will extend unwavering support to our industry partners in their growth endeavours.”

Mr. Pankaj Patwari, Managing Director, Advent International, said, “We are delighted to be able to announce today’s investment in Hyderabad’s thriving life sciences landscape. This expansion reaffirms our commitment to driving innovation, growth, and value creation in partnership with the dynamic ecosystem of the region. We are looking at making additional investments to further strengthen the position of the Cohance platform.” 

The growth story of Advent in Hyderabad’s life sciences sector serves as a testament to the robust partnership between global investors and the state’s thriving ecosystem. As the region continues to attract investments, it reaffirms Hyderabad’s reputation as a dynamic and promising destination for the life sciences industry. Furthermore, the collaboration between Advent and the Government of Telangana signifies the convergence of visionary leadership and a conducive business environment.